Skip to main content

Table 2 Correlation between cancer biomarkers and bone metastasis

From: Establishment of a biomarker model for predicting bone metastasis in resected stage III non-small cell lung cancer

Biomarkers

Bone metastasis n (%)

Non-bone metastasis n (%)

P value

OPN

+

40 (93.0)

48 (77.4)

0.033

 

-

3 (7.0)

14 (22.6)

 

c-Src

+

45 (100)

56 (93.3)

0.133

 

-

0 (0)

4 (6.7)

 

MMP2

+

38 (88.4)

47 (75.8)

0.107

 

-

5 (11.6)

15 (24.2)

 

CXCR4

+

40 (90.9)

32 (52.5)

0.000

 

-

4 (9.1)

29 (47.5)

 

BSP

+

44 (97.8)

49 (81.7)

0.012

 

-

1 (2.2)

11 (18.3)

 

PTHrP

+

42 (68.8)

28 (63.4)

0.647

 

-

19 (31.2)

16 (36.6)

 

IGF-1R

+

58 (95.1)

39 (88.6)

0.383

 

-

3 (4.9)

5 (21.4)

 

BMP4

+

22 (48.9)

51 (85)

0.000

 

-

23 (51.1)

9 (15.0)

 

PI3K

+

43 (95.6)

55 (91.7)

0.696

 

-

2 (4.4)

5 (8.3)

 

NFκB

+

58 (95.1)

39 (88.6)

0.383

 

-

3 (4.9)

5 (21.4)